Despite strong growth forecasts, Oncology Institute's low P/S ratio suggests shareholding doubts. Investors' optimism tests the P/S ratio due to potential risks, leading to future performance speculation.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more